Biotech Research

Found 2,400 articles

• Sarah Cannon Research Institute to Present Latest Oncology Research Insights at 2023 ASCO® Annual Meeting

  6/1/2023

  Sarah Cannon Research Institute announced that its network of research leaders have been selected to deliver insights through more than 135 abstracts and presentations at the 2023 American Society of Clinical Oncology Annual Meeting June 2-6, 2023.

• Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells

  6/1/2023

  Owkin, Nanostring, and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg, and Charité - Universitätsmedizin Berlin are launching MOSAIC at the American Society of Clinical Oncology’s annual meeting.

• Florida Cancer Specialists & Research Institute President & Managing Physician Lucio N. Gordan, MD Evaluates the Impact of Genomic Profiling

  6/1/2023

  Florida Cancer Specialists & Research Institute, LLC President & Managing Physician Lucio N. Gordan, MD, will join an expert panel of precision medicine leaders in Chicago this weekend to discuss the impact of genomic profiling.

• Ostentus Therapeutics, Inc., and City of Hope to Continue Studies of Novel OST Natural Products for Treatment of Leukemia and Other Cancers

  5/31/2023

  Ostentus Therapeutics, Inc., announced that it has entered into a second Sponsored Research Agreement with City of Hope, one of the largest cancer research and treatment organizations in the United States, to conduct preclinical research on OST compounds, which could be used as future therapies for leukemia and other cancers.

• Cubresa Installs First BrainPET Insert System at Lawson Health Research Institute

  5/30/2023

  Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute.

• City of Hope researchers will present new treatments for blood, prostate and other cancers at 2023 American Society of Clinical Oncology Annual Meeting

  5/26/2023

  City of Hope announced it would present research on promising treatments for blood, prostate and other cancers, as well as studies on germline testing for hereditary cancers and on reducing heart disease in childhood cancer survivors, at the 2023 American Society of Clinical Oncology's annual conference from June 2 to 6 in Chicago.

• Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Announce Three Late-Breaking Presentations at the 2023 ASCO Annual Meeting

  5/25/2023

  Rutgers Cancer Institute of New Jersey and RWJBarnabas Health announced that data from SWOG S1826 have been selected as late-breaking presentations at the 2023 American Society of Clinical Oncology Annual Meeting, to be held both in person in Chicago and online from June 2-6.

• Ivy Brain Tumor Center Builds On Innovative Clinical Trial Program by Appointing New Chief Medical OfficerLeading Neuro-Oncologist Yoshie Umemura, MD, Joins Barrow Neurological Institute

  5/23/2023

  The Ivy Brain Tumor Center and Barrow Neurological Institute are pleased to announce the addition of Yoshie Umemura, MD, as the new Chief Medical Officer of the Ivy Brain Tumor Center and Chief of Neuro-Oncology and the William and Joan Shapiro Chair of Neuro-Oncology at Barrow Neurological Institute.

• City of Hope presents new research on cancer immunotherapies at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

  5/22/2023

  City of Hope announced that one of its researchers will present results from a SWOG Cancer Research Network Phase 3 study comparing nivolumab and brentuximab vedotin in patients with advanced stage classic Hodgkin lymphoma at an ASCO press briefing.

• WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens

  5/19/2023

  WBB Research Institute (WBBRI) hosted a Demi-Colton Virtual Salon on the need for a global response to Candida auris and other deadly pathogens.

• From Seattle to Space: Science that Began at the Allen Institute Blasts off to International Space Station

  5/18/2023

  This Sunday at 2:37 p.m. PDT1, astronauts from Axiom Space in partnership with Cedars-Sinai will blast off to the International Space Station carrying cells from the Allen Institute for Cell Science, a division of the Allen Institute.

• Vivek Subbiah, MD, Joins SCRI to Advance Early-Phase Clinical Research

  5/11/2023

  Sarah Cannon Research Institute, one of the world’s leading oncology research organizations conducting clinical trials, is pleased to announce that Vivek Subbiah, MD, has joined the organization as Chief, Early-Phase Drug Development.

• Gwangju Institute of Science and Technology Researchers Develop Injectable Bioelectrodes with Tunable Lifetimes

  5/11/2023

  Implantable bioelectrodes are electronic devices that can monitor or stimulate biological activity by transmitting signals to and from living biological systems.

• Nagasaki University Presented Results Of a Specified Clinical Trial On The Use of L. lactis strain Plasma For Patients With COVID-19

  5/11/2023

  Nagasaki University presented the results of a specified clinical trial on patients with COVID-19 using Lactococcus.

• Research Shows That Early Rheumatoid Arthritis Diagnosis And Treatment Can Lower Healthcare Costs

  5/10/2023

  Rheumatoid arthritis is a chronic inflammatory disease associated with high economic burden to patients and health systems.

• NIH Study Investigates Factors Affecting Asthma With Frequent Symptom Flare Ups in Young Children

  5/10/2023

    [10-May-2023]   DURHAM, N.C. , May 10, 2023 /PRNewswire/ -- Young children, ages 2 to 4 years, especially those with parental history of asthma, suffered the highest rates of asthma with recurrent exacerbations (ARE) over a nearly 30-year period studied in new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.

• University of Missouri Laboratory for Infectious Disease Study Finds Technology Used in Widely Deployed Fingerprint Scanners Kills The Virus that Causes COVID-19

  5/9/2023

  Researchers at the University of Missouri Laboratory for Infectious Disease Research released the results of a study indicating that electroluminescent film technology, found in widely deployed biometric fingerprint scanners, actively kills SARS-CoV-2.

• Clinical Trial Shows Commonly Used Drug Has No Effect in Preventing Blood Clots, Hospitalization and Death

  5/8/2023

  Because millions of people experience fatal venous and arterial thrombosis – blood clots – per year and those with COVID-19 are at higher risk, researchers at The Feinstein Institutes for Medical Research helped to design and implement an entirely virtual, outpatient, cloud-based clinical trial to understand the efficacy of a common prophylactic medication: rivaroxaban.

• Feinstein Institutes’ 2023 Ross Prize awarded to fatty liver disease geneticists

  5/5/2023

  The Feinstein Institutes for Medical Research has selected two scientists from the University of Texas Southwestern Medical Center, Helen H. Hobbs, MD, and Jonathan C. Cohen, PhD, to receive the 10th annual Ross Prize in Molecular Medicine for groundbreaking research in dyslipidemias and metabolic liver disease.

• Florida Cancer Specialists & Research Institute President & Managing Physician Lucio Gordan, MD Featured Speaker at Nationwide Oncology Event

  5/4/2023

  Florida Cancer Specialists & Research Institute, LLC President & Managing Physician Lucio Gordan, MD is among the national experts and physician leaders at the ION Exchange 2023 this week in San Diego who will share the latest clinical, operational and business insights to advance the quality of cancer care in community settings.